No.	Year	Title	Author	Corresponding	Journal	Vol.	Pages
1	2014	Gastrointestinal motility and functional gastrointestinal diseases.	Kusano M, Hosaka H, Kawada A, Kuribayashi S, Shimoyama Y, Zai H, Kawamura O, Yamada M.	Kusano M	Curr Pharm Des	20
2	2014	Proton-sensing ovarian cancer G protein-coupled receptor 1 on dendritic cells is required for airway responses in a murine asthma model.	Aoki H, Mogi C, Hisada T, Nakakura T, Kamide Y, Ichimonji I, Tomura H, Tobo M, Sato K, Tsurumaki H, Dobashi K, Mori T, Harada A, Yamada M, Mori M, Ishizuka T, Okajima F.	Okajima F	PLoS One	11	e79985
3	2014	Hypothalamic SIRT1 prevents age-associated weight gain by improving leptin sensitivity in mice.	Sasaki T, Kikuchi O, Shimpuku M, Susanti VY, Yokota-Hashimoto H, Taguchi R, Shibusawa N, Sato T, Tang L, Amano K, Kitazumi T, Kuroko M, Fujita Y, Maruyama J, Lee YS, Kobayashi M, Nakagawa T, Minokoshi Y, Harada A, Yamada M, Kitamura T.	Sasaki T	Diabetologia	57	819-31
4	2014	Clinicopathological and prognostic significance of interleukin-8 expression and its relationship to KRAS mutation in lung adenocarcinoma.	Sunaga N, Kaira K, Tomizawa Y, Shimizu K, Imai H, Takahashi G, Kakegawa S, Ohtaki Y, Nagashima T, Kasahara N, Kawashima O, Hisada T, Saito R, Yamada M.	Sunaga N	Br J Cancer	110	2047-53
5	2014	A prospective randomized controlled study of endoscopic sphincterotomy with the Endocut mode or conventional blended cut mode.	Tanaka Y, Sato K, Tsuchida H, Mizuide M, Yasuoka H, Ishida K, Mori M, Kusano M, Yamada M.	Sato K	J Clin Gastroenterol	49	127-31
6	2014	ASC amino-acid transporter 2 (ASCT2) as a novel prognostic marker in non-small cell lung cancer.	Shimizu K, Kaira K, Tomizawa Y, Sunaga N, Kawashima O, Oriuchi N, Tominaga H, Nagamori S, Kanai Y, Yamada M, Oyama T, Takeyoshi I.	Kaira K	Br J Cancer	110	2030-2039
7	2014	Clinicopathological study of SDHB mutation-related pheochromocytoma and sympathetic paraganglioma.	Kimura N, Takekoshi K, Horii A, Morimoto R, Imai T, Oki Y, Saito T, Midorikawa S, Arao T, Sugisawa C, Yamada M, Otuka Y, Kurihara I, Sugano K, Nakane M, Fukuuchi A, Kitamoto T, Saito J, Nishikawa T, Naruse M.	Naruse M	Endocr Relat Cancer	21	L13-6
8	2014	ROCK activation in lung of idiopathic pulmonary fibrosis with oxidative stress.	Shimizu Y, Dobashi K, Sano T, Yamada M.	Dobashi K	Int J Immunopathol Pharmacol.	27	37-44
9	2014	Synip phosphorylation is required for insulin-stimulated Glut4 translocation and glucose uptake in podocyte.	Yamada E, Saito T, Okada S, Takahashi H, Ohshima K, Hashimoto K, Satoh T, Mori M, Okada J, Yamada M.	Okada S	Endocr J	61	523-7
10	2014	Small-cell lung cancer with voltage-gated calcium channel antibody-positive paraneoplastic limbic encephalitis: a case report.	Kaira K, Okamura T, Takahashi H, Horiguchi N, Sunaga N, Hisada T, Yamada M.	Kaira K	J Med Case Rep	8	119
11	2014	A case of thyroid storm with a markedly elevated level of circulating soluble interleukin-2 receptor complicated by multiple organ failure and disseminated intravascular coagulation syndrome.	Shimoda Y, Satoh T, Takahashi H, Katano-Toki A, Ozawa A, Tomaru T, Horiguchi N, Kaira K, Nishioka M, Shibusawa N, Hashimoto K, Wakino S, Mori M, Yamada M.	Satoh T	Endocr J	61	691-6
12	2014	Safety and efficacy of high-dose leukocytapheresis in patients with refractory asthma.	Ishizuka T, Hisada T, Hatori M, Koike A, Hanabuchi K, Matsuzaki S, Kamide Y, Utsugi M, Aoki H, Yoshino R, Yanagitani N, Koga Y, Ono A, Kaira K, Sunaga N, Dobashi K, Tsuburai T, Akiyama K, Yamada M, Suzuki K, Mori M	Ishizuka T	Inflamm Res	63	789-96
13	2014	Protection against high-fat diet-induced obesity in Helz2-deficient male mice due to enhanced expression of hepatic leptin receptor.	Yoshino S, Satoh T, Yamada M, Hashimoto K, Tomaru T, Katano-Toki A, Kakizaki S, Okada S, Shimizu H, Ozawa A, Tuchiya T, Ikota H, Nakazato Y, Mori M, Matozaki T, Sasaki T, Kitamura T, Mori M.	Satoh T	Endocrinology	155	3459-72
14	2014	Coordinated regulation of transcription and alternative splicing by the thyroid hormone receptor and its associating coregulators.	Satoh T, Katano-Toki A, Tomaru T, Yoshino S, Ishizuka T, Horiguchi K, Nakajima Y, Ishii S, Ozawa A, Shibusawa N, Hashimoto K, Mori M, Yamada M.	Satoh T	Biochem Biophys Res Commun	451	24−9
15	2014	Acidic pH increases cGMP accumulation through the OGR1/phospholipase C/Ca(2+)/neuronal NOS pathway in N1E-115 neuronal cells.	Kotake M, Sato K, Mogi C, Tobo M, Aoki H, Ishizuka T, Sunaga N, Imai H, Kaira K, Hisada T, Yamada M, Okajima F	Okajima F	Cell Signal	26	2326-32
16	2014	Surrogate endpoints for overall survival in advanced non-small-cell lung cancer patients with mutations of the epidermal growth factor receptor gene.	Yoshino R, Imai H, Mori K, Takei K, Tomizawa M, Kaira K, Yoshii A, Tomizawa Y, Saito R, Yamada M	Imai H	Mol Clin Oncol	2	731-736
17	2014	Somatic mutations of the catalytic subunit of cyclic AMP-dependent protein kinase (PRKACA) gene in Japanese patients with several adrenal adenomas secreting cortisol	Nakajima Y, Okamura T, Gohko T, Satoh T, Hashimoto K, Shibusawa N, Ozawa A, Ishii S, Tomaru T, Horiguchi K, Okada S, Takata D, Rokutanda N, Horiguchi J, Tsushima Y, Oyama T, Takeyoshi I, Yamada M.	Yamada M	Endocr J	61	825-32
18	2014	Nucleobindin-2 is a positive regulator for insulin-stimulated glucose transporter 4 translocation in fenofibrate treated E11 podocytes.	Saito T, Yamada E, Okada S, Shimoda Y, Tagaya Y, Hashimoto K, Satoh T, Mori M, Okada J, Pessin JE, Yamada M.	Okada S	Endocr J	61	933-9
19	2014	Photodynamic therapy for local recurrence of esophageal cancer in the esophagus after resection and free jejunal loop interposition for pharyngeal cancer.	Shimoyama Y, , Kuribayashi S, Kawada A, Hosaka H, Kawamura O, Tomizawa T, Sagawa T, Yasuoka H, Mizuide M, Yamada M.	Kusano M	Photodiagnosis Photodyn Ther	11	447-9
20	2014	The effects of concomitant GERD, dyspepsia, and rhinosinusitis on asthma symptoms and FeNO in asthmatic patients taking controller medications.	Ishizuka T, Hisada T, Kamide Y, Aoki H, Seki K, Honjo C, Sakai H, Kadowaki M, Umeda Y, Morikawa M, Anzai M, Ameshima S, Ishizaki T, Dobashi K, Yamada M, Kusano M.	Ishizuka T	J Asthma Allergy	7	131-9
21	2014	Expression of amino acid transporters (LAT1, ASCT2 and xCT) as clinical significance in hepatocellular carcinoma.	Namikawa M, Kakizaki S, Kaira K, Tojima H, Yamazaki Y, Horiguchi N, Sato K, Oriuchi N, Tominaga H, Sunose Y, Nagamori S, Kanai Y, Oyama T, Takeyoshi I, Yamada M.	Kakizaki S	Hepatol Res		doi: 10.1111/hepr.12431.
22	2014	Serum glycopeptidolipid core IgA antibody levels in patients with chest computed tomography features of mycobacterium aviumintracellulare complex pulmonary disease.	, Takise A, Morita H, Hosomi Y, Kasahara N, Kawata T, Horie T, Ishii Y, Yamada M.	Shimizu Y	J Biol Regul Homeost Agents	28	399-405
23	2014	Gastrointestinal symptoms in idiopathic pulmonary fibrosis patients treated with pirfenidone and herbal medicine.	Shimoyama Y, Kawada A, Kusano M, Hosomi Y, Sekiguchi M, Kawata T, Horie T, Ishii Y, Yamada M, Dobashi K, Takise A.	Shimizu Y	J Biol Regul Homeost Agents	28	433-42
24	2014	Tissue-specific posttranslational modification allows functional targeting of thyrotropin.	Ikegami K, Liao XH, Hoshino Y, Ono H, Ota W, Ito Y, Nishiwaki-Ohkawa T, Sato C, Kitajima K, Iigo M, Shigeyoshi Y, Yamada M, Murata Y, Refetoff S, Yoshimura T.	Yoshimura T	Cell Rep	9	801-10
25	2014	MK-0626, a selective DPP-4 inhibitor, attenuates hepatic steatosis in ob/ob mice.	Ohyama T, Sato K, Yamazaki Y, Hashizume H, Horiguchi N, Kakizaki S, Mori M, Kusano M, Yamada M.	Sato K	World J Gastroenterol	20	16227-35
26	2014	Glycosuria medicated with ipragliflozin and nifedipine or ipragliflozin and candesartan: a case report.	Okada S, Shibusawa R, Tagaya Y, Saito T, Yamada E, Shimoda Y, Satoh T, Okada J, Yamada M.	Okada S	J Med Case Rep	8	428
27	2014	A Case of Type 2 Amiodarone-Induced Thyrotoxicosis That Underwent Total Thyroidectomy under High-Dose Steroid Administration.	Hashimoto K, Ota M, Irie T, Takata D, Nakajima T, Kaneko Y, Tanaka Y, Matsumoto S, Nakajima Y, Kurabayashi M, Oyama T, Takeyoshi I, Mori M, Yamada M.	Hashimoto K	Case Rep Endocrinol		doi: 10.1155/2015/416145
28	2015	Clinical impact of post-progression survival on overall survival in patients with limited-stage disease small cell lung cancer after first-line chemoradiotherapy.	Kasahara N, Imai H, Kaira K, Mori K, Wakuda K, Ono A, Taira T, Kenmotsu H, Harada H, Naito T, Murakami H, Endo M, Nakajima T, Yamada M, Takahashi T.	Imai H	Radiol Oncol.	49	409-15
29	2015	Prognostic significance of diabetes mellitus in locally advanced non-small cell lung cancer.	Imai H, Kaira K, Mori K, Ono A, Akamatsu H, Matsumoto S, Taira T, Kenmotsu H, Harada H, Naito T, Murakami H, Endo M, Nakajima T, YamadaM, Takahashi T.	Kaira K	BMC Cancer.	15	989
30	2015	Protective Role of Proton-Sensing TDAG8 in Lipopolysaccharide-Induced Acute Lung Injury.	Tsurumaki H, Mogi C, Aoki-Saito H, Tobo M, Kamide Y, Yatomi M, Sato K, Dobashi K, Ishizuka T, Hisada T, Yamada M, Okajima F.	Okajima F	Int J Mol Sci.	16	28931-42
31	2015	Probable case of drug reaction with eosinophilia and systemic symptom syndrome due to combination therapy with daclatasvir and asunaprevir.	Suga T, Sato K, Yamazaki Y, Ohyama T, Horiguchi N, Kakizaki S, Kusano M, Yamada M.	Sato K	World J Clin Cases.	3	1005-10
32	2015	17(R)-resolvin D1 ameliorates bleomycin-induced pulmonary fibrosis in mice.	Yatomi M, Hisada T, Ishizuka T, Koga Y, Ono A, Kamide Y, Seki K, Aoki-Saito H, Tsurumaki H, Sunaga N, Kaira K, Dobashi K, Yamada M, Okajima F.	Hisada T	Physiol Rep.	3	e12628
33	2015	Effect of dapagliflozin on colon cancer cell [Rapid Communication].	Saito T, Okada S, Yamada E, Shimoda Y, Osaki A, Tagaya Y, Shibusawa R, Okada J, Yamada M.	Okada S	Endocr J.	62	1133-7
34	2016	Prevalence of nonalcoholic steatohepatitis in Japanese patients with morbid obesity undergoing bariatric surgery.	Seki Y, Kakizaki S, Horiguchi N, Hashizume H, Tojima H, Yamazaki Y, Sato K, Kusano M, Yamada M, Kasama K.	Kakizaki S	J Gastroenterol.	51	281-9
35	2016	Phase I dose escalation study of amrubicin plus paclitaxel in previously treated advanced non-small cell lung cancer	Kaira K, Sunaga N, Imai H, Kamide Y, Koga Y, Ono A, Kuwako T, Masuda T, Hisada T, Ishizuka T, Yamada M.	Kaira K	Int J Clin Oncol.	21	240-7
36	2015	First-line gefitinib treatment in elderly patients (aged ≥75 years) with non-small cell lung cancer harboring EGFR mutations.	Kuwako T, Imai H, Masuda T, Miura Y, Seki K, Yoshino R, Kaira K, Utsugi M, Shimizu K, Sunaga N, Tomizawa Y, Ishihara S, Ishizuka T, Mogi A,Hisada T, Minato K, Takise A, Saito R, Yamada M.	Imai H	Cancer Chemother Pharmacol.	76	761-9
37	2015	Tctex1d2 Is a Negative Regulator of GLUT4 Translocation and Glucose Uptake.	Shimoda Y, Okada S, Yamada E, Pessin JE, Yamada M.	Okada S	Endocrinology.	156	3548-58
38	2015	Acidic environment augments FcεRI-mediated production of IL-6 and IL-13 in mast cells.	Kamide Y, Ishizuka T, Tobo M, Tsurumaki H, Aoki H, Mogi C, Nakakura T, Yatomi M, Ono A, Koga Y, Sato K, Hisada T, Dobashi K, Yamada M,Okajima F.	Kamide Y	Biochem Biophys Res Commun.	464	949-55
39	2015	Response to Licinio et al.	Sato K, Hosonuma K, Kusano M, Yamada M.	Sato K	Am J Gastroenterol.	110	1086-7
40	2015	Efficacy of platinum combination chemotherapy after first-line gefitinib treatment in non-small cell lung cancer patients harboring sensitive EGFR mutations.	Masuda T, Imai H, Kuwako T, Miura Y, Yoshino R, Kaira K, Shimizu K, Sunaga N, Tomizawa Y, Ishihara S, Mogi A, Hisada T, Minato K, Takise A, Saito R,Yamada M.	Imai H	Clin Transl Oncol.	17	702-9
41	2015	Recurrent intimal sarcoma mimicking pulmonary embolism.	Kaira K, Imai H, Yamada M.	Kaira K	Jpn J Clin Oncol.	45	695-6
42	2015	A prospective randomized controlled study of long-term combination therapy using ursodeoxycholic acid and bezafibrate in patients with primary biliary cirrhosis and dyslipidemia.	Hosonuma K, Sato K, Yamazaki Y, Yanagisawa M, Hashizume H, Horiguchi N, Kakizaki S, Kusano M, Yamada M.	Sato K	Am J Gastroenterol.	110	423-31
43	2015	A prospective randomized controlled trial of AJG522 versus standard PEG+E as bowel preparation for colonoscopy.	Sagawa T, Sato K, Tomizawa T, Mizuide M, Yasuoka H, Shimoyama Y, Kuribayashi S, Kakizaki S, Kawamura O, Kusano M, Yamada M.	Sato K	Biomed Res Int.	2015	521756
44	2015	Evaluation of proton pump inhibitor-resistant nonerosive reflux disease by esophageal manometry and 24-hour esophageal impedance and pH monitoring.	Kawamura O, Hosaka H, Shimoyama Y, Kawada A, Kuribayashi S, Kusano M, Yamada M.	Kawamura O	Digestion.	91	19-25
45	2015	Variant parameter values-as defined by the Chicago Criteria-produced by ManoScan and a new system with Unisensor catheter.	Kuribayashi S, Iwakiri K, Kawada A, Kawami N, Hoshino S, Takenouchi N, Hosaka H, Shimoyama Y, Kawamura O, Yamada M, Kusano M.	Kuribayashi S	Neurogastroenterol Motil.	27	188-94
46	2015	More severe upper gastrointestinal symptoms associated with non-erosive reflux disease than with erosive gastroesophageal reflux disease during maintenance proton pump inhibitor therapy.	Kusano M, Hosaka H, Kawamura O, Kawada A, Kuribayashi S, Shimoyama Y, Yasuoka H, Mizuide M, Tomizawa T, Sagawa T, Sato K, Yamada M.	Kusano M	J Gastroenterol.	50	298-304
47	2015	A prospective randomized controlled study of endoscopic sphincterotomy with the Endocut mode or conventional blended cut mode.	Tanaka Y, Sato K, Tsuchida H, Mizuide M, Yasuoka H, Ishida K, Mori M, Kusano M, Yamada M.	Tanaka Y	J Clin Gastroenterol.	49	127-31
48	2016	Maturity onset diabetes of the young 5 accompanied by duodenal cysts.	Shimoda Y, Okada S, Shimoyama Y, Kusano M, Yamada M.	Okada S	J Diabetes.	8	448-9
49	2016	Interstitial pneumonia during administration of dipeptidyl peptidase-4 inhibitors.	Tagaya Y, Okada S, Hisada T, Niijima Y, Yamada M.	Okada S	J Diabetes.	8	442
50	2016	GNAS mutations in adrenal aldosterone-producing adenomas.	Nakajima Y, Okamura T, Horiguchi K, Gohko T, Miyamoto T, Satoh T, Ozawa A, Ishii S, Yamada E, Hashimoto K, Okada S, Takata D, Horiguchi J, Yamada M.	Yamada M	Endocr J.	63	199-204
51	2016	Malignant Peripheral Nerve Sheath Tumor of the Liver.	Kakizaki S, Horiguchi N, Otsuka T, Takizawa D, Yamazaki Y, Sato K, Ohno Y, Kusano M, Yamada M.	Kakizaki S	Intern Med.	55	245-9
52	2016	Insulin autoimmune syndrome during the administration of clopidogrel.	Yamada E, Okada S, Saito T, Osaki A, Ozawa A, Yamada M.	Yamada E	J Diabetes	8	588-9
53	2016	Endoscopic treatment for esophageal varices complicated by Isaacs’ syndrome involving difficulty with conventional sedation.	Suzuki Y, Yamazaki Y, Hashizume H, Kobayashi T, Ohyama T, Horiguchi N, Sato K, Kakizaki S, Kusano M, Yamada M.	Yamazaki Y	Clin J Gastroenterol	9	27-31
54	2016	Reversible Hypopituitarism Associated with Intravascular Large B-Cell Lymphoma: Case Report of Successful Immunochemotherapy.	Sawada Y, Ishii S, Koga Y, Tomizawa T, Matsui A, Tomaru T, Ozawa A, Shibusawa N, Satoh T, Shimizu H, Hirato J, Yamada M.	Ishii S	Tohoku J Exp Med	38	197-203
55	2016	Targeted Foxe1 Overexpression in Mouse Thyroid Causes the Development of Multinodular Goiter But Does Not Promote Carcinogenesis.	Nikitski A, Saenko V, Shimamura M, Nakashima M, Matsuse M, Suzuki K, Rogounovitch T, Bogdanova T, Shibusawa N, Yamada M, Nagayama Y, Yamashita S, Mitsutake N.	Mitsutake N	Endocrinology.	157	2182-95
56	2016	Combination therapy with daclatasvir and asunaprevir for dialysis patients infected with hepatitis C virus.	Sato K, Yamazaki Y, Ohyama T, Kobayashi T, Horiguchi N, Kakizaki S, Kusano M, Yamada M.	Sato K	World J Clin Cases	4	88-93
57	2016	CREB regulates TNF-α-induced GM-CSF secretion via p38 MAPK in human lung fibroblasts.	Koga Y, Hisada T, Ishizuka T, Utsugi M, Ono A, Yatomi M, Kamide Y, Aoki-Saito H, Tsurumaki H, Dobashi K, Yamada M.	Koga Y	Allergol Int	65	406-413
58	2016	Fatal fulminant hepatitis caused by infection with subgenotype A1 hepatitis B virus with C1766T/T1768A core promoter mutations.	Hoshino T, Takagi H, Suzuki Y, Naganuma A, Sato K, Kakizaki S, Nishizawa T, Okamoto H, Yamada M.	Hoshino T	Clin J Gastroenterol	9	160-7
59	2016	Renal threshold for glucose reabsorption predicts diabetes improvement by sodium-glucose cotransporter 2 inhibitor therapy.	Osaki A, Okada S, Saito T, Yamada E, Ono K, Niijima Y, Hoshi H, Yamada M.	Okada S	J Diabetes Investig.	7	751-4
60	2016	Clinical Significance of the Relationship between Progression-Free Survival or Postprogression Survival and Overall Survival in Patients with Extensive Disease-Small-Cell Lung Cancer Treated with Carboplatin plus Etoposide.	Imai H, Mori K, Watase N, Fujimoto S, Kaira K, Yamada M, Minato K.	Imai H	Can Respir J.
61	2016	APPL1 promotes glucose uptake in response to mechanical stretch via the PKCζ-non-muscle myosin IIa pathway in C2C12 myotubes.	Saito T, Okada S, Shimoda Y, Tagaya Y, Osaki A, Yamada E, Shibusawa R, Nakajima Y, Ozawa A, Satoh T, Mori M, Yamada M.	Saito T	Cell Signal.	28	1694 -702
62	2016	Fyn phosphorylates AMPK to inhibit AMPK activity and AMP-dependent activation of autophagy.	Yamada E, Okada S, Bastie CC, Vatish M, Nakajima Y, Shibusawa R, Ozawa A, Pessin JE, Yamada M.	Yamada E	Oncotarget.	7	74612- 74629
63	2016	Elemental and immunohistochemical analysis of the lungs and hilar lymph node in a patient with asbestos exposure, a pilot study.	Koga Y, Satoh T, Kaira K, Koka M, Hisada T, Hirato J, Altan B, Yatomi M, Ono A, Kamide Y, Shimizu Y, Aoki-Saito H, Tsurumaki H, Shimizu K, Mogi A, Ishizuka T, Yamada M, Dobashi K.	Koga Y	Environ Health Prev Med	21	492-500
64	2016	Nivolumab-induced hypophysitis in a patient with advanced malignant melanoma.	Okano Y, Satoh T, Horiguchi K, Toyoda M, Osaki A, Matsumoto S, Tomaru T, Nakajima Y, Ishii S, Ozawa A, Shibusawa N, Shimada T, Higuchi T, Chikamatsu K, Yamada M.	Satoh T	Endocr J	63	905-912
65	2016	Clinical impact of post-progression survival on overall survival in elderly patients with extensive disease small-cell lung cancer.	Imai H, Mori K, Watase N, Kazama T, Fujimoto S, Kaira K, Yamada M, Minato K.	Imai H	Thorac Cancer	7	655-662
66	2016	Effect of carbohydrate counting using bolus calculators on glycemic control in type 1 diabetes patients during continuous subcutaneous insulin infusion.	Yamada E, Okada S, Nakajima Y, Bastie CC, Tagaya Y, Osaki A, Shimoda Y, Shibusawa R, Saito T, Ozawa A, Yamada M.	Yamada E	J Diabetes Investig	10	1111- 12604
67	2016	Usefulness of 18F-α-Methyltyrosine PET for Therapeutic Monitoring of Patients with Advanced Lung Cancer.	Kaira K, Higuchi T, Sunaga N, Arisaka Y, Hisada T, Tominaga H, Oriuchi N, Asao T, Tsushima Y, Yamada M.	Kaira K	Anticancer Res.	36	6481- 6490
68	2016	Subcutaneous abdominal adipose tissue is associated with an index of insulin sensitivity/resistance.	Niijima K, Shimoda Y, Saito T, Yamada E, Niijima Y, Okada S, Yamada M.	Okada S	Adipocyte.	5	375-377
69	2017	Elevated 1-h post-challenge glucose levels associated with increased arterial stiffness.	Saito T, Niijima K, Yamada E, Niijima Y, Okada S, Yamada M.	Okada S	J Diabetes	9	102-103
70	2017	Characteristics of Japanese aldosterone-producing adenomas with KCNJ5 mutations.	Okamura T, Nakajima Y, Katano-Toki A, Horiguchi K, Matsumoto S, Yoshino S, Yamada E, Tomaru T, Ishii S, Saito T, Ozawa A, Shibusawa N, Satoh T, Okada S, Nagaoka R, Takada D, Horiguchi J, Oyama T, Yamada M.	Nakajima Y	Endocr J	64	39-47
71	2017	Whole-Exome Sequencing Study of Thyrotropin-Secreting Pituitary Adenomas.	Sapkota S, Horiguchi K, Tosaka M, Yamada S, Yamada M.		J Clin Endocrinol Metab	102	566-575
72	2017	Combination Therapy with Ombitasvir/Paritaprevir/Ritonavir for Dialysis Patients Infected with Hepatitis C Virus: A Prospective Multi-Institutional Study.	Sato K, Hosonuma K, Yamazaki Y, Kobayashi T, Takakusagi S, Horiguchi N, Kakizaki S, Kusano M, Ohnishi H, Okamoto H, Yamada M.	Sato K	Tohoku J Exp Med	241	45-53
73	2017	Evaluation of gefitinib efficacy according to body mass index, body surface area, and body weight in patients with EGFR-mutated advanced non-small cell lung cancer.	Imai H, Kuwako T, Kaira K, Masuda T, Miura Y, Seki K, Sakurai R, Utsugi M, Shimizu K, Sunaga N, Tomizawa Y, Ishihara S, Ishizuka T, Mogi A, Hisada T, Minato K, Takise A, Saito R, Yamada M.	Imai H	Cancer Chemother Pharmacol	79	497-505
74	2017	Autochthonous sporadic acute hepatitis E caused by two distinct subgenotype 3b hepatitis E virus strains with only 90% nucleotide identity.	Yamaguchi Y, Takagi H, Suzuki Y, Maruhashi K, Kosone T, Kakizaki S, Sato K, Yamada M, Nagashima S, Takahashi M, Okamoto H.	Okamoto H.	Clin J Gastroenterol.	10(2)	168-173
75	2017	Drug-induced Liver injury Caused by Ipragliflozin Administration with Causality Established by a Positive Lymphocyte Transformation Test (LTT) and the Roussel Uclaf Causality Assessment Method (RUCAM): A Case Report.	Niijima K, Niijima Y, Okada S, Yamada M.	Okada S	Ann Hepatol.	16(2)	308-311
76	2017	Plasma epidermal growth factor receptor mutation testing with a chip-based digital PCR system in patients with advanced non-small cell lung cancer.	Kasahara N, Kenmotsu H, Serizawa M, Umehara R, Ono A, Hisamatsu Y, Wakuda K, Omori S, Nakashima K, Taira T, Naito T, Murakami H, Koh Y, Mori K, Endo M, Nakajima T, Yamada M, Kusuhara M, Takahashi T.	Kenmotsu H	Lung Cancer.	106	138-144
77	2017	Spontaneous remission of hepatitis B virus reactivation during direct-acting antiviral agent-based therapy for chronic hepatitis C.	Sato K, Kobayashi T, Yamazaki Y, Takakusagi S, Horiguchi N, Kakizaki S, Kusano M, Yamada M.	Sato K	Hepatol Res.	47(12):	1346-1353
78	2017	Isolated Gastric Varices Refractory to Balloon-occluded Retrograde Transvenous Obliteration (BRTO) Successfully Treated by Shunt-occluded Endoscopic Injection Sclerotherapy (SO-EIS): A Case Report and Review of the Literature.	Hatanaka T, Kakizaki S, Suzuki Y, Ueno T, Shimada Y, Takizawa D, Katakai K, Sato K, Kusano M, Yamada M.	Kakizaki S	Intern Med	56(9)	1041-1048
79	2017	Factors predicting overall response and overall survival in hepatocellular carcinoma patients undergoing balloon-occluded transcatheter arterial chemoembolization: A retrospective cohort study.	Hatanaka T, Arai H, Shibasaki M, Tojima H, Takizawa D, Toyoda M, Takayama H, Abe T, Sato K, Kakizaki S, Yamada M.	Kakizaki S	Hepatol Res.	48(2)	165-175
80	2017	Amrubicin monotherapy may be an effective second-line treatment for patients with large-cell neuroendocrine carcinoma or high-grade non-small-cell neuroendocrine carcinoma.	Kasahara N, Wakuda K, Omori S, Nakashima K, Ono A, Taira T, Kenmotsu H, Naito T, Murakami H, Mori K, Watanabe R, Endo M, Nakajima T, Yamada M, Takahashi T.	Wakuda K	Mol Clin Oncol.	6(5)	718-722
81	2017	Assessment of factors determining an HbA1c concentration ≤7.5% in patients with type 1 diabetes.	Yamada E, Okada S, Nakajima Y, Bastie C, Tagaya Y, Osaki A, Shimoda Y, Shibusawa R, Saito T, Ozawa A, Yamada M.	Yamada M	J Diabetes.	10(2)	140-147
82	2017	High expression of GRP78/BiP as a novel predictor of favorable outcomes in patients with advanced thymic carcinoma.	Miura Y, Kaira K, Sakurai R, Imai H, Tomizawa Y, Sunaga N, Minato K, Hisada T, Oyama T, Yamada M.	Kaira K	Int J Clin Oncol.	22(5)	872-879
83	2017	Increase of transient lower esophageal sphincter relaxation associated with cascade stomach.	Kawada A, Kusano M, Hosaka H, Kuribayashi S, Shimoyama Y, Kawamura O, Akiyama J, Yamada M, Akuzawa M.	Kusano M	J Clin Biochem Nutr.	60(3):	211-215
84	2017	Serum sodium ion level influenced by daily salt intake after administration of sodium-glucose cotransporter 2 inhibitors.	Yamada E, Osaki A, Saito T, Niijima Y, Okada J, Okada S, Yamada M.	Okada S	Nutrition.	45	146
85	2017	Prospective exploratory study of gemcitabine and S-1 against elderly patients with advanced non-small cell lung cancer.	Kaira K, Yanagitani N, Sunaga N, Imai H, Ono A, Koga Y, Hisada T, Ishizuka T, Yamada M.	Kaira K	Oncol Lett.	14(1)	1123-1128
86	2017	High expression of nucleobindin 2 is associated with poor prognosis in gastric cancer.	Altan B, Kaira K, Okada S, Saito T, Yamada E, Bao H, Bao P, Takahashi K, Yokobori T, Tetsunari O, Nishiyama M, Yamada M.	Kaira K	Tumour Biol.	39(7)	1010428317703810
87	2017	An Autopsy Case of Fulminant Hepatitis in a Patient with Multiple Sclerosis Treated by Interferon-Beta-1a.	Yamazaki Y, Suzuki A, Hirayanagi K, Tsukagoshi Y, Uehara R, Horiguchi K, Ohyama T, Tomaru T, Horiguchi N, Nobusawa S, Ikota H, Sato K, Kakizaki S, Kusano M, Ikeda Y, Yokoo H, Yamada M.	Yamazaki Y	Intern Med.	56(14):	1897-1901
88	2017	Sodium glucose co-transporter 2 inhibitors successfully attenuated seasonal change of glycated haemoglobin A1c.	Yamada E, Saito T, Niijima Y, Okada S, Yamada M.	Okada S	Clin Med (Lond).	17(4)	377-378
89	2017	Prognostic effect of class III β-tubulin and Topoisomerase-II in patients with advanced thymic carcinoma who received combination chemotherapy, including taxanes or topoisomerase-II inhibitors.	Miura Y, Kaira K, Sakurai R, Imai H, Tomizawa Y, Sunaga N, Minato K, Hisada T, Oyama T, Yamada M.	Kaira K	Oncol Lett.	14(2)	2369-2378
90	2017	Pituitary NR4A1 is negatively regulated by thyroid hormone without direct binding of thyroid hormone receptors on the gene.	Okamura T, Nakajima Y, Shibusawa N, Horiguchi K, Matsumoto S, Yamada E, Tomaru T, Ishii S, Ozawa A, Ishizuka T, Hashimoto K, Okada S, Satoh T, Yamada M.	Yamada M	Mol Cell Endocrinol.	461	32-42
91	2017	Association between Skeletal Muscle Depletion and Sorafenib Treatment in Male Patients with Hepatocellular Carcinoma: A Retrospective Cohort Study	Naganuma A, Hoshino T, Suzuki Y, Uehara D, Kudo T, Ishihara H, Sato K, Kakizaki S, Yamada M, Takagi H.	Takagi H.	Acta Med Okayama	71(4)	291-299
92	2017	Elevated serum uric acid level was a notable adverse event during combination therapy with sofosbuvir and ribavirin.	Sato K, Naganuma A, Nagashima T, Hoshino T, Uehara D, Arai Y, Horiuchi K, Yuasa K, Takayama H, Arai H, Hatanaka T, Ohyama T, Tahara H, Sohara N, Kobayashi T, Horiguchi N, Yamazaki Y, Kakizaki S, Kusano M, Yamada M, Murase T, Nakamura T.	Sato K	Hepatol Res.	48(3)	E347-E353.
93	2017	Isoniazid-induced Pure Red Cell Aplasia in a Patient with Sarcoidosis: A Patient Summary and Review of the Literature.	Saito Y, Sawada Y, Koga Y, Sunaga N, Tsukagoshi Y, Hachisu Y, Osaki T, Sakurai R, Kaira K, Ono A, Sato K, Koiso H, Oyama T, Hisada T, Yamada M.	Saito Y	Intern Med.	56(20)	2753-2757
94	2017	Efficacy and safety of once-monthly pasireotide in Cushing’s disease: a 12 month clinical trial.	Lacroix A, Gu F, Gallardo W, Pivonello R, Yu Y, Witek P, Boscaro M, Salvatori R, Yamada M, Tauchmanova L, Roughton M, Ravichandran S, Petersenn S, Biller BMK, Newell-Price J; Pasireotide G2304 Study Group.	Lacroix A	Lancet Diabetes Endocrinol.	6(1)	17-26
95	2017	Sialic Acid-Binding Immunoglobulin-Like Lectin1 as a Novel Predictive Biomarker for Relapse in Graves’ Disease: A Multicenter Study.	Hashimoto K, Nishihara E, Matsumoto M, Matsumoto S, Nakajima Y, Tsujimoto K, Yamakage H, Satoh-Asahara N, Noh JY, Ito K, Miyauchi A, Mori M, Yamada M, Ogawa Y.	Hashimoto K	Thyroid	28(1):	50-59
96	2017	Sodium Glucose Cotransporter 2 Inhibition Combined With Cetuximab Significantly Reduced Tumor Size and Carcinoembryonic Antigen Level in Colon Cancer Metastatic to Liver.	Okada J, Matsumoto S, Kaira K, Saito T, Yamada E, Yokoo H, Katoh R, Kusano M, Okada S, Yamada M.	Okada S	Clin Colorectal Cancer.	17(1)	e45-e48.
97	2017	Specific Light-Up System for Protein and Metabolite Targets Triggered by Initiation Complex Formation.	Fujita H, Kataoka Y, Nagano R, Nakajima Y, Yamada M, Sugimoto N, Kuwahara M.	Kuwahara M.	Sci Rep	7(1)	15191
98	2017	A phase II study of biweekly gemcitabine and carboplatin in completely resected stage IB-IIIA non-small cell lung cancer.	Sakurai R, Tomizawa Y, Yoshii A, Miura Y, Tsurumaki H, Kaira K, Sunaga N, Kawashima O, Hisada T, Yamada M, Saito R.	Sakurai R,	Cancer Chemother Pharmacol.	81(1)	103-109
99	2017	Hypercalcemia after the Discontinuation of Medroxyprogesterone Acetate.	Yuasa-Shibasaki E, Ishii S, Matsumoto S, Tomaru T, Horiguchi K, Osaki A, Ozawa A, Shibusawa N, Satoh T, Yamada M.	Satoh T	Intern Med.	57(4)	545-549
100	2017	High expression of topoisomerase-II predicts favorable clinical outcomes in patients with relapsed small cell lung cancers receiving amrubicin.	Miura Y, Kaira K, Sakurai R, Sunaga N, Saito R, Hisada T, Yamada M.	Kaira K,	Lung Cancer.	115	42-48
101	2018	Adrenal Ewing’s Sarcoma in an Elderly Man.	Toda K, Ishii S, Yasuoka H, Nishioka M, Kobayashi T, Horiguchi K, Tomaru T, Ozawa A, Shibusawa N, Satoh T, Koshi H, Segawa A, Shimizu SI, Oyama T, Yamada M.	Ishii S	Intern Med.	57(4)	551-555.
102	2018	Thyroid-Related Research in Japan A Spotlight on Recent Important Contributions.	Murata Y, Yamada M.	Murata Y,	Thyroid	28(1)
103	2018	Efficacy and safety of metyrosine in pheochromocytoma/paraganglioma: a multi-center trial in Japan.	Naruse M, Satoh F, Tanabe A, Okamoto T, Ichihara A, Tsuiki M, Katabami T, Nomura M, Tanaka T, Matsuda T, Imai T, Yamada M, Harada T, Kawata N, Takekoshi K.	Naruse M	Endocr J.	65(3):	359-371
104	2018	Mild Maternal Hypothyroxinemia During Pregnancy Induces Persistent DNA Hypermethylation in the Hippocampal Brain-Derived Neurotrophic Factor Gene in Mouse Offspring.	Kawahori K, Hashimoto K, Yuan X, Tsujimoto K, Hanzawa N, Hamaguchi M, Kase S, Fujita K, Tagawa K, Okazawa H, Nakajima Y, Shibusawa N, Yamada M, Ogawa Y.	Hashimoto K	Thyroid	28(3)	395-406
105	2018	Usage of continuous glucose monitoring (CGM) for detecting an unrecognized hypoglycemia and management of glucocorticoid replacement therapy in adult patients with central hypoadrenalism.	Watanabe T, Ozawa A, Ishii S, Tomaru T, Shibusawa N, Saito T, Yamada E, Horiguchi K, Nakajima Y, Matsumoto S, Yoshino S, Katano-Toki A, Hashimoto K, Mori M, Okada S, Satoh T, Yamada M.	Yamada M	Endocr J	10	1507
106	2018	Transducin β-like 1, X-linked and nuclear receptor co-repressor cooperatively augment the ligand-independent stimulation of TRH and TSHβ gene promoters by thyroid hormone receptors.	Takamizawa T, Satoh T, Miyamoto T, Nakajima Y, Ishizuka T, Tomaru T, Yoshino S, Katano-Toki A, Nishikido A, Sapkota S, Watanabe T, Okamura T, Ishida E, Horiguchi K, Matsumoto S, Ishii S, Ozawa A, Shibusawa N, Okada S, Yamada M.	Satoh T	Endocr J	65(8)	805-813
107	2018	Correlation Between Lateralization Index of Adrenal Venous Sampling and Standardized Outcome in Primary Aldosteronism.	Umakoshi H, Tsuiki M, Yokomoto-Umakoshi M, Takeda Y, Takashi Y, Kurihara I, Itoh H,	Naruse M	J Endocr Soc.	2(8)	893-902
108	2018	Variation of measured values associated with different lots of sensors for the FreeStyle Libre.	Okada J, Yamada E, Saito T, Okada S, Yamada M.	Okada S	J Diabetes	10(12)	986-987
109	2018	Mouse models of sporadic thyroid cancer derived from BRAFV600E alone or in combination with PTEN haploinsufficiency under physiologic TSH levels.	Shimamura M, Shibusawa N, Kurashige T, Mussazhanova Z, Matsuzaki H, Nakashima M, Yamada M, Nagayama Y.	Nagayama Y.	PLoS One	13(8)	e0201365
110	2019	Metformin administration attenuates dipeptidyl peptidase-4 inhibitor-induced increases in Krebs von den Lungen-6 (KL-6) levels.	Okada J, Yamada E, Niijima Y, Okada S, Yamada M.	Okada S	J Diabetes.	11(1)	95-96.
111	2019	SGLT1 in pancreatic α cells regulates glucagon secretion in mice, possibly explaining the distinct effects of SGLT2 inhibitors on plasma glucagon levels.	Suga T, Kikuchi O, Kobayashi M, Matsui S, Yokota-Hashimoto H, Wada E, Kohno D, Sasaki T, Takeuchi K, Kakizaki S, Yamada M, Kitamura T.	Kitamura T.	Mol Metab.	19	1-12.
112	2019	Constitutive androstane receptor and pregnane X receptor cooperatively ameliorate DSS-induced colitis.	Uehara D, Tojima H, Kakizaki S, Yamazaki Y, Horiguchi N, Takizawa D, Sato K, Yamada M, Uraoka T.	Kakizaki S	Dig Liver Dis.	51(2)	226-235
113	2019	Dipeptidyl peptidase-4 inhibitors attenuate thyroid-stimulating hormone concentrations.	Okada J, Yamada E, Niijima Y, Okada S, Yamada M.	Okada S	J Diabetes.
114	2019	Contribution of Thyrotropin-Releasing Hormone to Cerebellar Long-Term Depression and Motor Learning.	Watanave M, Matsuzaki Y, Nakajima Y, Ozawa A, Yamada M, Hirai H.	Yamada M	Front Cell Neurosci.		490
115	2019	Non-invasive prediction of non-alcoholic steatohepatitis in Japanese patients with morbid obesity by artificial intelligence using rule extraction technology.	Uehara D, Hayashi Y, Seki Y, Kakizaki S, Horiguchi N, Tojima H, Yamazaki Y, Sato K, Yasuda K, Yamada M, Uraoka T, Kasama K.	Yamada M	World J Hepatol.	10(12)	934-943.
116	2019	Age-Dependent Progression of Renal Dysfunction After Adrenalectomy for Aldosterone-Producing Adenomas in Japan	Yoshioka M, Nakajima Y, Miyamoto T, Igarashi T, Sakamaki K, Akuzawa M, Ishida E, Horiguchi K, Yamada E, Saito T, Ozawa A, Shimomura Y, Kobayashi I, Andou Y, Shirabe K, Yamada M.	Yamada M	J Endocr Soc.	3(3)	577-589.
117	2019	Efficacy of Vonoprazan, a Novel Potassium-Competitive Acid Blocker, in Patients with Proton Pump Inhibitor-Refractory Acid Reflux.	Akiyama J, Hosaka H, Kuribayashi S, Moriyasu S, Hisada Y, Okubo H, Watanabe K, Imbe K, Nagata N, Kojima Y, Yokoi C, Uemura N, Shimoyama Y, Kawamura O, Yamada M, Kusano M.	Yamada M	Digestion.		1-13
118	2019	In situ condensation of an anti-cancer drug into fibrin gel enabling effective inhibition of tumor cell growth.	Kuwahara M, Fujita H, Kataoka Y, Nakajima Y, Yamada M,	Sugimoto N.	Chem Commun (Camb).	55(78)	11679-11682
119	2019	Influence of Smoking on Thyroid Function in Japanese Subjects: Longitudinal Study for One Year of On-Off Smoking.	Nakajima Y, Yamada S, Nishikido A, Katano-Toki A, Ishida E, Akuzawa M, Sakamaki K, Yamada E, Saito T, Ozawa A, Okada S, Shimomura Y, Kobayashi I, Andou Y,	Yamada M.	J Endocr Soc.	3(12)	2385-2396
120	2019	Dapagliflozin rescues endoplasmic reticulum stress-mediated cell death.	Shibusawa R, Yamada E, Okada S, Nakajima Y, Bastie CC, Maeshima A, Kaira K,	Yamada M.	Sci Rep	9(1)	9887
121	2019	Lower Renal Threshold for Glucose Reabsorption in Type 1 Diabetes Mellitus (T1DM) May Explain the Smaller Contribution of SGLT2 Inhibitors to the Improvement of Plasma Glucose Control Compared with T2DM.	Osaki A, Shimoda Y, Okada J, Yamada E, Saito T, Nakajima Y, Ozawa A, Niijima Y, Okada S,	Yamada M	Diabetes Ther	10(4)	1531-1534
122	2019	Analysis of FAM19A2/TAFA-2 function.	Okada J, Yamada E, Saito T, Ozawa A, Nakajima Y, Pessin JE, Okada S,	Yamada M.	Physiol Behav.	208	11258
123	2019	Basal Autophagy Deficiency Causes Thyroid Follicular Epithelial Cell Death in Mice.	Kurashige T, Nakajima Y, Shimamura M, Matsuyama M, Yamada M, Nakashima M,	Nagayama Y	Endocrinology	160(9)	2085-2092
124	2019	Renal impairment is closely associated with plasma aldosterone concentration in patients with primary aldosteronism.	Kawashima A, Sone M, Inagaki N, Takeda Y, Itoh H, Kurihara I, Umakoshi H, Ichijo T, Katabami T, Wada N, Ogawa Y, Kawashima J, Fujita M, Miyauchi S, Okamura S, Fukuoka T, Yanase T, Izawa S, Yoshikawa Y, Hashimoto S, Yamada M, Kai T, Suzuki T,	Naruse M	Eur J Endocrinol	181(3)	339-350
125	2019	Latent Autonomous Cortisol Secretion From Apparently Nonfunctioning Adrenal Tumor in Nonlateralized Hyperaldosteronism.	Ohno Y, Sone M, Inagaki N, Takeda Y, Kurihara I, Tsuiki M, Ichijo T, Wada N, Katabami T, Ogawa Y, Okamura S, Fukuoka T, Kai T, Izawa S, Yoshikawa Y, Hashimoto S, Yamada M, Chiba Y,	Naruse M	J Clin Endocrinol Metab.	104(10)	4382-4389
126	2019	Central Hypothyroidism Related to Pituitary Adenomas: Low Incidence of Central Hypothyroidism in Patients With Acromegaly.	Takamizawa T, Horiguchi K, Nakajima Y, Okamura T, Ishida E, Matsumoto S, Yoshino S, Yamada E, Saitoh T, Ozawa A, Tosaka M, Yamada S,	Yamada M.	J Clin Endocrinol Metab.	104(10)	4879-4888
127	2019	Comparison of serum amylase level between dipeptidyl peptidase-4 inhibitor and GLP-1 analog administration in patients with type 2 diabetes mellitus.	Okada J, Yamada E, Niijima Y, Okada S,	Yamada M.	J Health Popul Nutr.	38(1)	33
128	2019	Hypofractionated carbon-ion radiotherapy for stage I peripheral nonsmall cell lung cancer (GUNMA0701): Prospective phase II study.	Saitoh JI, Shirai K, Mizukami T, Abe T, Ebara T, Ohno T, Minato K, Saito R, Yamada M,	Nakano T.	Cancer Med.	8(15)	6644-6650.
129	2019	Resolvin E3 attenuates allergic airway inflammation via the interleukin-23-interleukin-17A pathway.	Sato M, Aoki-Saito H, Fukuda H, Ikeda H, Koga Y, Yatomi M, Tsurumaki H, Maeno T, Saito T, Nakakura T, Mori T, Yanagawa M, Abe M, Sako Y, Dobashi K, Ishizuka T, Yamada M, Shuto S, Hisada T.		FASEB J.	33(11)	12750-12759
130	2019	Correlation between urinary fractionated metanephrines in 24-hour and spot urine samples for evaluating the therapeutic effect of metyrosine: a subanalysis of a multicenter, open-label phase I/II study.	Takekoshi K, Satoh F, Tanabe A, Okamoto T, Ichihara A, Tsuiki M, Katabami T, Nomura M, Tanaka T, Matsuda T, Imai T, Yamada M, Asada S, Kawata N,	Naruse M.	Endocr J.	66(12)	1063-1072
131	2019	Genetics of Congenital Isolated TSH Deficiency: Mutation Screening of the Known Causative Genes and a Literature Review.	Sugisawa C, Takamizawa T, Abe K, Hasegawa T, Shiga K, Sugawara H, Ohsugi K, Muroya K, Asakura Y, Adachi M, Daitsu T, Numakura C, Koike A, Tsubaki J, Kitsuda K, Matsuura N, Taniyama M, Ishii S, Satoh T, Yamada M,	Narumi S.	J Clin Endocrinol Metab.	104(12)	6229-6237
132	2020	Inhibition of sodium glucose cotransporter-2 affects HbA1c levels in people with insulin-dependent diabetes mellitus and differing levels of glucagon.	Okada J, Yamada E, Okada S,	Yamada M.	Prim Care Diabetes.	S1751-9918(19)	30583-2
133	2020	Dapagliflozin Inhibits Cell Adhesion to Collagen I and IV and Increases Ectodomain Proteolytic Cleavage of DDR1 by Increasing ADAM10 Activity.	Okada J, Yamada E, Saito T, Yokoo H, Osaki A, Shimoda Y, Ozawa A, Nakajima Y, Pessin JE, Okada S,	Yamada M.	Molecules.	25(3)	495
134	2020	Evaluation of the relationship between glycated hemoglobin A1c and mean glucose levels derived from the professional continuous flash glucose monitoring system.	Yamada M, Okada S, Oda H, Nakajima Y, C Bastie C, Kasai Y, Osaki A, Shimoda Y, Shibusawa R, Uehara R, Saito T, Ozawa A,	Yamada E.	Endocr J.
135	2020	Assessment of factors that determine the mean absolute relative difference in flash glucose monitoring with reference to plasma glucose levels in Japanese subjects without diabetes.	Yoshino S, Yamada E, Okada S, Nakajima Y, Shibusawa R, Uehara R, Matsumoto S, Horiguchi K, Ishida E, Saito T,	Yamada M.	Endocr J.
136	2020	Clinical significance of topoisomerase-II expression in patients with advanced non-small cell lung cancer treated with amrubicin.	Sakurai R, Kaira K, Miura Y, Sunaga N, Saito R, Oyama T, Hisada T,	Yamada M.	Thorac Cancer.	11(2)	426-435
137	2020	Regulation of the KCNJ5 gene by SF-1 in the adrenal cortex: Complete genomic organization and promoter function.	Nishikido A, Okamura T, Nakajima Y, Ishida E, Miyamoto T, Toki AK, Matsumoto S, Yoshino S, Horiguchi K, Saito T, Yamada E, Ozawa A, Shimoda Y, Oyama T,	Yamada M.	Mol Cell Endocrinol.	501	110657
138	2020	Basal Plasma Aldosterone Concentration Predicts Therapeutic Outcomes in Primary Aldosteronism.	Saiki A, Otsuki M, Mukai K, Hayashi R, Shimomura I, Kurihara I, Ichijo T, Takeda Y, Katabami T, Tsuiki M, Wada N, Ogawa Y, Kawashima J, Sone M, Inagaki N, Yoshimoto T, Okamoto R, Takahashi K, Kobayashi H, Tamura K, Kamemura K, Yamamoto K, Izawa S, Kakutani M, Yamada M, Tanabe A, Naruse M.		J Endocr Soc.	4(4)
139	2020	Chicken ovalbumin upstream promoter-transcription factor II protects against cisplatin-induced acute kidney injury.	Ishii S, Yamada M,	Koibuchi N.	Endocr J.	67(3)	283-293
140	2020	Diabetes Mellitus Itself Increases Cardio-Cerebrovascular Risk and Renal Complications in Primary Aldosteronism	Saiki A, Otsuki M, Tamada D, Kitamura T, Shimomura I, Kurihara I, Ichijo T, Takeda Y, Katabami T, Tsuiki M, Wada N, Yanase T, Ogawa Y, Kawashima J, Sone M, Inagaki N, Yoshimoto T, Okamoto R, Takahashi K, Kobayashi H, Tamura K, Kamemura K, Yamamoto K, Izawa S, Kakutani M, Yamada M, Tanabe A, Naruse M.	Naruse M.	J Clin Endocrinol Metab.	Jul 1;105(7)
141	2020	Transcriptional Regulation of the Angptl8 Gene by Hepatocyte Nuclear Factor-1 in the Murine Liver	Watanabe T, Ozawa A, Masuda S, Yoshino S, Ishida E, Kondo Y, Matsumoto S, Katano-Toki A, Horiguchi K, Nakajima Y, Yamada E, Tomaru T, Saito T, Ishii S, Shibusawa N, Okada S, Satoh T, Yamada M.	Ozawa A	Sci Rep.	Jun 19;10(1)
142	2020	FAM83G Is a Novel Inducer of Apoptosis	Okada J, Sunaga N, Yamada E, Saito T, Ozawa A, Nakajima Y, Okada K, Pessin JE, Okada S, Yamada M.	Okada S	Molecules.	Jun 18;25(12):	2810
143	2020	Hormonal Regulation of Autophagy in Thyroid PCCL3 Cells and the Thyroids of Male Mice	Kurashige T, Nakajima Y, Shimamura M,?Yamada M, Nagayama Y.	Nagayama Y.	J Endocr Soc.	May 15;4(7)
144	2020	Administration of small-molecule guanabenz acetate attenuates fatty liver and hyperglycemia associated with obesity	Yoshino S, Iwasaki Y, Matsumoto S, Satoh T, Ozawa A, Yamada E, Kakizaki S, Trejo JAO, Uchiyama Y,?Yamada M, Mori M.	Mori M.	Sci Rep.	Aug 13;10(1):	13671
145	2020	Ipragliflozin-induced improvement of liver steatosis in obese mice may involve sirtuin signaling	Suga T, Sato K, Ohyama T, Matsui S, Kobayashi T, Tojima H, Horiguchi N, Yamazaki Y, Kakizaki S, Nishikido A, Okamura T,?Yamada M, Kitamura T, Uraoka T.	Sato K	World J Hepatol.	Jul 27;12(7)	:350-362.
146	2020	Comparing the efficacy of apple peels and a sodium-glucose cotransporter 2 inhibitor (ipragliflozin) on interstitial glucose levels: A pilot case study	Okada J, Yamada E, Okada K, Okada S,?Yamada M.	Okada S	Curr Ther Res Clin Exp.	Jul 25;93:	100597
147	2020	Post-progression survival is strongly linked to overall survival in refractory small-cell lung cancer patients who received amrubicin	Imai H, Kaira K, Mori K, Watase N, Hisada T,?Yamada M, Minato K.	Kaira K	J Cancer Res Ther	Jul-Sep;16(4)	764-770.
148	2020	Differences in the effects of Kenyan, Tanzanian, and Ethiopian coffee intake on interstitial glucose levels measured by FreeStyle Libre: A pilot case study	Okada J, Osaki A, Shimoda Y, Yamada E, Saito T, Ozawa A, Nakajima Y, Okada K, Okada S, Yamada M.	Okada S	Curr Ther Res Clin Exp.	Sep 19;93	:100606
149	2020	Inhibition of sodium glucose cotransporter-2 affects HbA1c levels in people with insulin-dependent diabetes mellitus and differing levels of glucagon	Okada J, Yamada E, Okada S,Yamada M.		Prim Care Diabetes	Oct;14(5)	570-571.
150	2021	In patients with type 2 diabetes the presence of Hashimoto’s thyroiditis reduces the beneficial effect of dipeptidyl peptidase-4 inhibitor on plasma glucose control	Watanabe T, Temma Y, Okada J, Yamada E, Saito T, Osaki A, Shimda Y, Matsumoto S, Horiguchi K, Ishida E, Kondo Y, Okada K, Takamizawa T, Nakajima Y, Ozawa A, Okada S, Horigome M,?Yamada M.	Okada S	Endocr J. 2021	Jan 7.
151	2021	Association of aldosterone and blood pressure with the risk for cardiovascular events after treatments in primary aldosteronism	Haze T, Hirawa N, Yano Y, Tamura K, Kurihara I, Kobayashi H, Tsuiki M, Ichijo T, Wada N, Katabami T, Yamamoto K, Oki K, Inagaki N, Okamura S, Kai T, Izawa S, Yamada M, Chiba Y, Tanabe A, Naruse M.	Naruse M.	Atherosclerosis.	Mar 29;324	:84-90.
152	2021	Late-onset non-islet cell tumor hypoglycemia: A case report	Matsumoto S, Yamada E, Nakajima Y, Yamaguchi N, Okamura T, Yajima T, Yoshino S, Horiguchi K, Ishida E, Yoshikawa M, Nagaoka J, Sekiguchi S, Sue M, Okada S, Fukuda I, Shirabe K, Yamada M.	Yamada E	World J Clin Cases.	Jan 6;9(1):	163-169
153	2021	Angiotensin receptor blockers significantly reduce hemoglobin level in patients with type 2 diabetes mellitus not suffered chronic cardiac failure and chronic kidney disease	Watanabe T, Temma Y, Okada J, Yamada E, Ishida E, Horiguchi K, Saito T, Okada K, Takamizawa T, Nakajima Y, Ozawa A, Okada S, Horigome M, Yamada M.	Okada S	Endocr J.	Apr 28;68(4)	:503-507.
154	2021	Influence of the stage of emergency declaration due to the coronavirus disease 2019 outbreak on plasma glucose control of patients with diabetes mellitus in the Saku region of Japan	Watanabe T, Temma Y, Okada J, Yamada E, Saito T, Okada K, Nakajima Y, Ozawa A, Takamizawa T, Horigome M, Okada S, Yamada M.	Okada S	J Rural Med.	Apr;16(2)	:98-101.
155	2021	TBC1D8B, a GTPase-activating protein, is a novel apoptosis inducer	Okada J, Matsumoto S, Yamada E, Saito T, Okada K, Watanabe T, Nakajima Y, Ozawa A, Yamada M, Ohshima K, Okada S.	Okada S.	Biomed Res.	42(3)	95-102.
156	2021	Overexpressed exocyst complex component 3-like 1 spontaneously induces apoptosis	Matsumoto S, Okada J, Yamada E, Saito T, Okada K, Watanabe T, Nakajima Y, Ozawa A, Okada S, Yamada M.	Okada S.	Biomed Res.	42(3)	109-113.
157	2021	Influence of the stage of emergency declaration due to the coronavirus disease 2019 outbreak on plasma glucose control of patients with diabetes mellitus in the Saku region of Japan	Watanabe T, Temma Y, Okada J, Yamada E, Saito T, Okada K, Nakajima Y, Ozawa A, Takamizawa T, Horigome M, Okada S, Yamada M.	Okada S.	J Rural Med.	16(2)	98-101.
158	2021	Angiotensin receptor blockers significantly reduce hemoglobin level in patients with type 2 diabetes mellitus not suffered chronic cardiac failure and chronic kidney disease	Watanabe T, Temma Y, Okada J, Yamada E, Ishida E, Horiguchi K, Saito T, Okada K, Takamizawa T, Nakajima Y, Ozawa A, Okada S, Horigome M, Yamada M.	Okada S.	Endocr J.	;68(4)	503-507.
159	2021	Association of aldosterone and blood pressure with the risk for cardiovascular events after treatments in primary aldosteronism	Haze T, Hirawa N, Yano Y, Tamura K, Kurihara I, Kobayashi H, Tsuiki M, Ichijo T, Wada N, Katabami T, Yamamoto K, Oki K, Inagaki N, Okamura S, Kai T, Izawa S, Yamada M, Chiba Y, Tanabe A, Naruse M.		Atherosclerosis.	324	84-90.
160	2021	In patients with type 2 diabetes the presence of Hashimoto’s thyroiditis reduces the beneficial effect of dipeptidyl peptidase-4 inhibitor on plasma glucose control	Watanabe T, Temma Y, Okada J, Yamada E, Saito T, Osaki A, Shimda Y, Matsumoto S, Horiguchi K, Ishida E, Kondo Y, Okada K, Takamizawa T, Nakajima Y, Ozawa A, Okada S, Horigome M, Yamada M.		Endocr J.	68(5)	599-603.
161	2021	SFPQ associated with a co-activator for PPARγ, HELZ2, regulates key nuclear factors for adipocyte differentiation	Katano-Toki A, Yoshino S, Nakajima Y, Tomaru T, Nishikido A, Ishida E, Horiguchi K, Saito T, Ozawa A, Satoh T, Yamada M.	Katano-Toki A	Biochem Biophys Res Commun.	562	139-145.
162	2021	Association of achieved blood pressure after treatment for primary aldosteronism with long-term kidney function	Haze T, Yano Y, Hatano Y, Tamura K, Kurihara I, Kobayashi H, Tsuiki M, Ichijo T, Wada N, Katabami T, Yamamoto K, Okamura S, Kai T, Izawa S, Yoshikawa Y, Yamada M, Chiba Y, Tanabe A, Naruse M	Yano Y	J Hum Hypertens.	36(10)	904-910
163	2021	Superior Mesenteric Artery Syndrome Accompanied by Acute-onset Type 1 Diabetes Complicated with Graves’ Disease: A Case Report	Sue-Nagumo M, Matsumoto S, Yamada E, Nakajima Y, Yoshino S, Horiguchi K, Ishida E, Okada S, Yamada M.	Matsumoto S.	Intern Med.	61(10)	1555-1560
164	2021	Free triiodothyronine /free thyroxine ratio as an index of deiodinase type 1 and 2 activities negatively correlates with casual serum insulin levels in patients with type 2 diabetes mellitus	Okada J, Isoda A, Hoshi H, Watanabe T, Yamada E, Saito T, Okada K, Nakajima Y, Ozawa A, Ohshima K, Yamada M, Okada S.	Okada S.	Endocr J.	68(10)	1237-1240.
165	2021	The Optimal “Time in Range” and “Time below Range” are Difficult to Coordinate in Patients with Type 1 Diabetes.	Sekiguchi S, Yamada E, Nakajima Y, Matsumoto S, Yoshino S, Horiguchi K, Ishida E, Uehara R, Okada S, Yamada M.	Yamada E.	Tohoku J Exp Med.	255(3)	221-227.
166	2021	Pitfalls of intermittent continuous glucose monitoring in patients with steroid diabetes	Yamada E, Sekiguchi S, Nakajima Y, Uehara R, Okada S, Yamada M.	Yamada E.	Endocr J.	68(11)	1367-1372.
167	2021	Subtype-specific trends in the clinical picture of primary aldosteronism over a 13-year period	Saito K, Kurihara I, Itoh H, Ichijo T, Katabami T, Tsuiki M, Wada N, Yoneda T, Sone M, Oki K, Yamada T, Kobayashi H, Tamura K, Ogawa Y, Kawashima J, Inagaki N, Yamamoto K, Yamada M, Kamemura K, Fujii Y, Suzuki T, Yasoda A, Tanabe A, Naruse M	Kurihara I	J Hypertens.	39(11)	2325-2332.
168	2022	The Hypothalamic Paraventricular Nucleus Is the Center of the Hypothalamic-Pituitary-Thyroid Axis for Regulating Thyroid Hormone Levels	Kondo Y, Ozawa A, Kohno D, Saito K, Buyandalai B, Yamada S, Horiguchi K, Nakajima Y, Shibusawa N, Harada A, Yokoo H, Akiyama H, Sasaki T, Kitamura T, Yamada M.	Yamada M.	Thyroid.	32(1)	105-114.
169	2022	Oxytocin Facilitates Allomaternal Behavior under Stress in Laboratory Mice.	Tsuneoka Y, Yoshihara C, Ohnishi R, Yoshida S, Miyazawa E, Yamada M, Horiguchi K, Young WS, Nishimori K, Kato T, Kuroda KO.	Kuroda KO	eNeuro. 0405-21.	9(1)	0405-21.
170	2022	Casual C peptide index: Predicting the subsequent need for insulin therapy in outpatients with type 2 diabetes under primary care	Uehara R, Yamada E, Nakajima Y, Osaki A, Okada S, Yamada M.	Yamada E	J Diabetes.	14(3)	221-227.
171	2022	Resolvin E3 ameliorates high-fat diet-induced insulin resistance via the phosphatidylinositol-3-kinase/Akt signaling pathway in adipocytes	Shimizu T, Saito T, Aoki-Saito H, Okada S, Ikeda H, Nakakura T, Fukuda H, Arai S, Fujiwara K, Nakajima Y, Horiguchi K, Yamada S, Ishida E, Hisada T, Shuto S, Yamada M.	Saito T.	FASEB J.	36(3)	e22188.